Transmission and prevention: latest news

Transmission and prevention resources

  • Transmission and viral load

    An undetectable viral load shows that HIV treatment is working well and that there is very little HIV in body fluids.In this situation, the risk...

    From: The basics

    Information level Level 1
  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Post-exposure prophylaxis (PEP)

    PEP involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV.Doctors will assess your risk of HIV infection before prescribing PEP.PEP is available from...

    From: Factsheets

    Information level Level 2
  • HIV and having a baby

    Women living with HIV can give birth without passing on HIV to the baby.Your options for conception will depend on your health and your partner’s...

    From: Factsheets

    Information level Level 2
  • HIV transmission

    The two main ways in which HIV is passed on are unprotected vaginal and anal sex.Condoms, PrEP and HIV treatment are effective ways of preventing...

    From: Factsheets

    Information level Level 2
  • Viral load and transmission – a factsheet for HIV-negative people

    People with HIV who are on treatment and have an undetectable viral load are extremely unlikely to pass on HIV.Large scientific studies have proven this.Not...

    From: Factsheets

    Information level Level 2
  • Viral load and transmission – a factsheet for people with HIV

    Effective HIV treatment reduces the amount of HIV in your body fluids.Having an undetectable viral load greatly reduces your chance of passing HIV on to...

    From: Factsheets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Sex and HIV

    Sex, desire and pleasure need not stop when you have an HIV diagnosis. Women continue to be sexually active and to have fulfilling sexual and emotional relationships. Many...

    From: Booklets

    Information level Level 2
  • Sex

    Having HIV can affect people’s feelings about sex in many different ways. Some people become anxious about passing HIV on, or feel less desirable. While some people go...

    From: Booklets

    Information level Level 2
  • Transmission of drug-resistant virus

    Some people contract HIV that is already resistant to one or more anti-HIV drugs (this has been the case for between 6 and 10% of people in...

    From: Booklets

    Information level Level 2
  • HIV treatment as prevention

    This briefing paper, produced by NAM for HIV Prevention England, describes the scientific evidence for HIV treatment as prevention and considers its implications for the UK....

    From: HIV prevention briefing papers

  • Undiagnosed HIV infection

    This briefing paper, produced by NAM for HIV Prevention England, covers undiagnosed HIV infection and late diagnosis of HIV in the UK....

    From: HIV prevention briefing papers

  • Oral sex

    Many people enjoy giving and receiving oral sex – kissing, licking or sucking another person’s genitals.The risk of getting HIV from performing oral sex on someone with HIV...

    From: Factsheets

    Information level Level 2
  • Bacterial vaginosis

    Bacterial vaginosis may occur when the balance of bacteria in the vagina becomes disrupted. Symptoms include changes to vaginal discharge and a fishy smell.Having bacterial vaginosis increases the risk...

    From: Factsheets

    Information level Level 2
  • Behaviour change

    A practical introduction to the evidence regarding the effectiveness of non-biomedical HIV prevention methods....

    From: Preventing HIV

    Information level Level 4
  • Post-exposure prophylaxis

    Post-exposure prophylaxis (PEP) has been in use, in healthcare settings, since 1988. Providing PEP after sexual exposure is more controversial....

    From: Preventing HIV

    Information level Level 4
  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4
  • Microbicides

    Microbicides are any substances which protect people against infection by microbes, such as viruses or bacteria, on contact with those microbes....

    From: Preventing HIV

    Information level Level 4
  • Preventing HIV

    An essential resource providing evidence-based information on preventing HIV infection. ...

    From: Aidsmap 2.0

    Information level Level 4
  • Risk

    An examination of prosecuted behaviours, using scientific evidence to determine actual risk, and how this evidence has been applied in jurisdictions worldwide....

    From: HIV & the criminal law

    Information level Level 4
  • HIV transmission & testing

    A practical guide to the complexities surrounding HIV transmission routes, risks and HIV testing. ...

    From: Aidsmap 2.0

    Information level Level 4

Transmission and prevention features

Transmission and prevention in your own words

  • Bored and horny

    It’s Sunday afternoon and it’s raining. I’m bored and horny. However, I’ve got £20 left over from the night before and this will be enough...

    From: In your own words

Transmission and prevention news from aidsmap

More news

Transmission and prevention news selected from other sources

  • Open letter to Gilead Sciences about PrEP by EATG and the PrEP in Europe Initiative

    Please read and share this letter signed by the European AIDS Treatment Group and the PrEP in Europe Initiative (PEI), a partnership of European prevention and policy NGOs. It requests Gilead Sciences to surrender their patent of Truvada® or otherwise make it possible for Truvada or generic equivalents of it to be offered at greatly reduced prices to all European health care systems so that it can be used as HIV pre-exposure prophylaxis (PrEP).

    18 April 2017 | EATG / PrEP in Europe
  • The real sex lives of gay men - GMFA's biggest survey

    GMFA has just conducted its biggest-ever sex survey for the 150th edition of its resource FS. Ian Howley, Chief Executive of GMFA, said: “With over 3,000 responses it gives a fascinating snapshot of the kind of sex that gay and bisexual men in the UK are having, what they enjoy and what they are doing, or not doing, to maintain their sexual health.”

    13 April 2017 | GMFA
  • Where Is PrEP? HIV Charities Warn The NHS Will Miss Its Own Deadline

    Britain's top HIV organisations have accused NHS England of dragging its feet in providing the prevention drug, despite 17 people a day contracting the virus.

    30 March 2017 | BuzzFeed
  • HIV Activist Learning Modules: Engaging our Community in HIV Prevention Policy Advocacy

    In order to support the efforts of prevention advocates across the United States, Treatment Action Group has developed a series of modules to help support activists’ capacity needs and to develop advocacy action plans. The slides and handouts in each module focus on how to identify and change the governmental, organizational, and institutional policies that create roadblocks to comprehensive HIV prevention in our communities. The materials are useful for personal education or group discussion on HIV prevention and policy advocacy.

    29 March 2017 | TAG
  • Welsh report says HIV prevention drug 'highly effective'

    PrEP has "clear potential" to prevent people catching the virus, a Welsh Government-commissioned report has said. It is not currently available on the Welsh NHS.

    22 March 2017 | BBC
  • Breastfeeding with an undetectable viral load: what do we know?

    Megan DePutter on why undetectable does not equal untransmittable in the case of breastfeeding, but why women should be supported to make an informed choice anyway.

    08 March 2017 | Positive Lite
  • FPA welcomes government announcement on relationships and sex education

    FPA is delighted that the Secretary of State, Justine Greening, has announced today (Wednesday 1 March) that, in England, every child from the age of four will be taught about safe and healthy relationships and, later, about sex.

    01 March 2017 | FPA
  • What we know about the new England PrEP trial

    @teamPrEPster, and other HIV advocate groups, will be keeping a watchful eye on development of the trial, not least to ensure that there are no further delays to its implementation.

    27 February 2017 | Prepster
  • HIV diagnoses falling steeply, early figures show: London clinics see hope in increased use of pre-exposure prophylaxis

    Early figures from four London sexual health clinics reveal a steep decline in the rate of HIV diagnoses in 2016, raising the possibility that the virus could be managed out of existence in the UK. The fall might be explained by the increased use of medicines called pre-exposure prophylaxis, or PrEP. The medicines are provided by the clinics but are also for sale online, though they are not available on the NHS.

    13 January 2017 | Financial Times
  • Bacterial communities of female genital tract impact HIV infection risk

    More diverse vaginal microbiomes in South African women may underlie increased risk

    12 January 2017 | Ragon Institute
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.